Green tea extract can cause insomnia, increased heart rate, and nervousness because of its caffeine content
Lower Risk Across All Key Outcomes with GLP-1RA Compared with DPP-4 inhibitors, GLP-1RA use was associated with significantly lower risks of MACE (hazard ratio [HR]: 0.66), VTE (HR: 0.49), kidney disease progression (HR: 0.77), and all-cause mortality (HR: 0.26)
Class I inhibitors are U-shaped and specifically bind to the ATP-binding site of c-MET (often via hydrogen bonding with the residue Met1160), thus showing higher selectivity than class II inhibitors [21, 23]
This section covers what is known about safety along with theoretical concerns
View the current JRNYS program details (official JRNYS page) JRNYS GLP-1 Medication Options: Semaglutide, Tirzepatide, Liraglutide, Ozempic, Mounjaro, Wegovy, and Zepbound JRNYS-affiliated providers may discuss and prescribe medications across several GLP-1 and related categories
Elderly patients may be more susceptible to adverse effects such as dehydration, particularly if experiencing nausea, vomiting, or diarrhoea